Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism
- 1 April 2015
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 135 (4) , 659-665
- https://doi.org/10.1016/j.thromres.2015.02.003
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention
This publication has 41 references indexed in Scilit:
- Antithrombotic Therapy for VTE DiseaseChest, 2012
- Risk assessment for recurrent venous thrombosisThe Lancet, 2010
- Venous ThromboembolismAmerican Journal of Preventive Medicine, 2010
- Biomarkers and Venous ThromboembolismArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- The effects of race/ethnicity and sex on the risk of venous thromboembolismCurrent Opinion in Pulmonary Medicine, 2007
- Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 monthsJournal of Thrombosis and Haemostasis, 2006
- Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort studyThe Lancet, 2003
- Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification SystemAnnals of Internal Medicine, 2003
- Risk Factors for Deep Vein Thrombosis and Pulmonary EmbolismArchives of internal medicine (1960), 2000
- Predictors of Recurrence After Deep Vein Thrombosis and Pulmonary EmbolismArchives of internal medicine (1960), 2000